更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
伊芙琳合伙投资管理服务有限公司减持安捷伦科技股份 - MarketBeat
Evelyn Partners Investment Management Services Ltd Reduces Stock Position in Agilent Technologies, Inc. $A MarketBeat
眼疾治疗管线下一步进展如何?
What’s next in the eye disease pipeline? An early gene therapy breakthrough spurred investments, but can the industry maintain momentum? Published Nov. 24, 2025 By Kell...
2025年威特斯公司(WAZ)股票能否跑赢能源板块?——投资组合更新报告与长期稳健投资计划 - newser.com
Will Waters Corporation (WAZ) stock outperform energy sector in 2025 - Portfolio Update Report & Long-Term Safe Investment Plans newser.com
安捷伦科技(AG8)股票是否准备好迎接数字化转型——周投资回顾与基于AI的买卖信号——newser.com
Is Agilent Technologies Inc. (AG8) stock prepared for digital transition - Weekly Investment Recap & AI Based Buy and Sell Signals newser.com
隆萨集团普通股(LO3A)对美元走强的反应——投资组合风险报告与免费长期投资增长策略 - 新闻网站报道
How Lonza Group AG (Common Stock) (LO3A) stock reacts to stronger dollar - Portfolio Risk Report & Free Long-Term Investment Growth Plans newser.com
Thermo Fisher美国投资如何影响其采购战略——《采购杂志》
How Thermo Fisher's US Investment Impacts Sourcing Strategy Procurement Magazine
Cytiva以16亿美元战略投资完成亚洲、美国和欧洲项目 - BioSpectrum Asia
Cytiva completes projects in Asia, US & Europe with $1.6 B strategic investment BioSpectrum Asia
Cytiva公布至2028年16亿美元设施投资计划 - 国际生物工艺
Cytiva outlines $1.6bn facility investment plans through 2028 BioProcess International
Cytiva完成16亿美元战略投资,进一步强化全球供应链布局 - 基因工程与生物技术新闻
Cytiva Completes $1.6 billion in Strategic Investments to Further Enhance Global Supply Chain GEN - Genetic Engineering and Biotechnology News
罗氏宣布投资5.5亿美元扩建印第安纳波利斯诊断制造中心——美通社
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub PR Newswire
罗氏效仿同行,向美国制造与研发基地投入500亿美元——FirstWord Pharma
Roche follows peers with $50B investment in US manufacturing, research sites FirstWord Pharma
Vaxcyte将Lonza位于Visp工厂的制造投资列为2024年关键支出——生物工艺国际报道
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure BioProcess International
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页